# King's Invasive Aspergillosis Study II

> **NCT02875743** · PHASE4 · COMPLETED · sponsor: **King's College Hospital NHS Trust** · enrollment: 120 (actual)

## Conditions studied

- Aplastic Anemia
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Bone Marrow Transplantation

## Interventions

- **DRUG:** Posaconazole

## Key facts

- **NCT ID:** NCT02875743
- **Lead sponsor:** King's College Hospital NHS Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-07
- **Primary completion:** 2018-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02875743

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02875743, "King's Invasive Aspergillosis Study II". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02875743. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*